LTFS
EBS icon

Ladenburg Thalmann Financial Services’s Emergent Biosolutions EBS Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$576K Sell
10,658
-436
-4% -$23.6K ﹤0.01% 1691
2019
Q3 		$580K Sell
11,094
-261
-2% -$12.2K ﹤0.01% 1642
2019
Q2 		$528K Sell
11,355
-372
-3% -$17.8K ﹤0.01% 1701
2019
Q1 		$592K Buy
11,727
+760
+7% +$44.8K ﹤0.01% 1574
2018
Q4 		$650K Sell
10,967
-1,409
-11% -$90.8K 0.01% 1347
2018
Q3 		$814K Sell
12,376
-1,200
-9% -$70K 0.01% 1258
2018
Q2 		$715K Hold
13,576
– – 0.01% 1280
2018
Q1 		$715K Buy
13,576
+952
+8% +$47.4K 0.01% 1280
2017
Q4 		$587K Buy
12,624
+50
+0.4% +$2.1K 0.01% 1438
2017
Q3 		$509K Buy
12,574
+1,062
+9% +$38.4K 0.01% 1457
2017
Q2 		$390K Buy
11,512
+10,412
+947% +$321K ﹤0.01% 1546
2017
Q1 		$32K Buy
1,100
+950
+633% +$28.9K ﹤0.01% 3233
2016
Q4 		$5K Hold
150
– – ﹤0.01% 4209
2016
Q3 		$5K Sell
150
-905
-86% -$26.3K ﹤0.01% 4139
2016
Q2 		$30K Buy
1,055
+371
+54% +$14.5K ﹤0.01% 3057
2016
Q1 		$25K Buy
684
+116
+20% +$4.1K ﹤0.01% 3090
2015
Q4 		$23K Buy
568
+204
+56% +$7.11K ﹤0.01% 3114
2015
Q3 		$10K Buy
364
+89
+32% +$2.93K ﹤0.01% 3526
2015
Q2 		$9K Buy
275
+135
+96% +$4.18K ﹤0.01% 3735
2015
Q1 		$4K Buy
140
+94
+204% +$2.7K ﹤0.01% 4056
2014
Q4 		$1K Buy
+46
New +$1.1K ﹤0.01% 4192

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ladenburg Thalmann Financial Services's EBS Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Emergent Biosolutions (EBS) stake by 3.9% in Q4 2019, selling an estimated $23.6K and leaving 10,658 shares worth $576K. The position accounts for ﹤0.01% of the portfolio, ranked #1691.

Ladenburg Thalmann Financial Services first reported a position in EBS in Q4 2014 and has held it in 21 quarters since. The position peaked at $814K in Q3 2018. 236 funds tracked by Wall St. Rank hold EBS as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 10,658 shares of Emergent Biosolutions worth $576K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 436 Emergent Biosolutions shares in Q4 2019, an estimated $23.6K.
  • Emergent Biosolutions made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #1691 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Emergent Biosolutions in Q4 2014 and has held it in 21 quarters since.
  • Ladenburg Thalmann Financial Services's Emergent Biosolutions position peaked at $814K in Q3 2018.
  • 236 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.